BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38622913)

  • 1. LncRNA NEAT1 in the pathogenesis of liver-related diseases.
    Saleh RO; Alkhafaji AT; Mohammed JS; Bansal P; Kaur H; Ahmad I; Hjazi A; Mohammed IH; Jawad MA; Zwamel AH
    Cell Biochem Funct; 2024 Apr; 42(3):e4006. PubMed ID: 38622913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3.
    Jin SS; Lin XF; Zheng JZ; Wang Q; Guan HQ
    Eur Cytokine Netw; 2019 Sep; 30(3):98-106. PubMed ID: 31957704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms and therapeutic potential of long noncoding RNA NEAT1 in fibrosis.
    Jiang X
    Clin Exp Med; 2023 Nov; 23(7):3339-3347. PubMed ID: 37740135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases.
    Bu FT; Wang A; Zhu Y; You HM; Zhang YF; Meng XM; Huang C; Li J
    Liver Int; 2020 Nov; 40(11):2612-2626. PubMed ID: 32745314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway.
    Jin SS; Lin CJ; Lin XF; Zheng JZ; Guan HQ
    Ann Hepatol; 2022; 27(2):100584. PubMed ID: 34808393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling.
    Sun Y; Song Y; Liu C; Geng J
    Biochem Biophys Res Commun; 2019 Aug; 516(2):584-590. PubMed ID: 31239155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis.
    Ye J; Lin Y; Yu Y; Sun D
    J Transl Med; 2020 Nov; 18(1):445. PubMed ID: 33228663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA NEAT1 regulates gastric carcinoma cell proliferation, invasion and apoptosis via the miR‑500a‑3p/XBP‑1 axis.
    Zhou Y; Sha Z; Yang Y; Wu S; Chen H
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate
    Huang W; Huang F; Zhang R; Luo H
    Cell Cycle; 2021; 20(5-6):490-507. PubMed ID: 33550894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway.
    Dong Y; Hu M; Tan K; Dai R
    Epigenetics; 2023 Dec; 18(1):2239592. PubMed ID: 37566742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the long noncoding RNA NEAT1 in carcinogenesis.
    Klec C; Prinz F; Pichler M
    Mol Oncol; 2019 Jan; 13(1):46-60. PubMed ID: 30430751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
    Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
    Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.
    Hu MJ; Long M; Dai RJ
    Mol Cell Biochem; 2022 Jan; 477(1):191-203. PubMed ID: 34652536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential.
    Li K; Yao T; Zhang Y; Li W; Wang Z
    Int J Biol Sci; 2021; 17(13):3428-3440. PubMed ID: 34512157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of LncRNA NEAT1 in Gastric Cancer: Tumor Development and Potential Therapeutic Target.
    Zhang Y; Wen Y
    Curr Pharm Des; 2023; 29(28):2213-2222. PubMed ID: 37779403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6.
    Yu F; Jiang Z; Chen B; Dong P; Zheng J
    J Mol Med (Berl); 2017 Nov; 95(11):1191-1202. PubMed ID: 28864835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA Nuclear Paraspeckle Assembly Transcript 1 (NEAT1)Relieves Sepsis-Induced Kidney Injury and Lipopolysaccharide (LPS)-Induced Inflammation in HK-2 Cells.
    Gao C; Zou X; Chen H; Shang R; Wang B
    Med Sci Monit; 2020 Jul; 26():e921906. PubMed ID: 32724027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NEAT1 Accelerates the Proliferation, Oxidative Stress, Inflammation, and Fibrosis and Suppresses the Apoptosis Through the miR-423-5p/GLIPR2 Axis in Diabetic Nephropathy.
    Wu X; Fan D; Chen B
    J Cardiovasc Pharmacol; 2022 Mar; 79(3):342-354. PubMed ID: 34803150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA nuclear enriched abundant transcript 1 impacts cell proliferation, invasion, and migration of glioma through regulating miR-139-5p/ CDK6.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Zheng YL
    J Cell Physiol; 2019 May; 234(5):5972-5987. PubMed ID: 30515782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.
    Chen X; Tan XR; Li SJ; Zhang XX
    Life Sci; 2019 Oct; 235():116829. PubMed ID: 31484042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.